Features of complex medicamental therapy in patients with silent myocardial ischemia of high risk after myocardial infarction
Conclusions: The silent myocardial ischemia, which is associated with the presence of such Rfs as arterial hypertension, diabetes melitus, dyslipidemia or their combination, is characterized by a severe course of the disease, which is manifested by a worsening of the clinical condition, a decrease in tolerance to physical exertion, significant changes in hemodynamics.
Authors
- Tetiana V. Naluzhna (ORCID: https://orcid.org/0000-0003-0840-5355)
- Khrystyna Levandovska (ORCID: https://orcid.org/0000-0003-3259-7940)
- Т. V. Merhel (ORCID: https://orcid.org/0000-0002-8017-3475)
Institutions
- Ivano-Frankivsk National Medical University (UA)
Publication Details
- Journal
- Wiadomości Lekarskie
- Published
- 2025-02-28
- DOI
- https://doi.org/10.36740/wlek/201337
- Primary Topic
- Healthcare Systems and Public Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00